CYP24A1 and vitamin D deficiency: Given that the prevalence of pathogenic CYP24A1 mutations is very low and considering the beneficial effects of preventing and treating vitamin D deficiency, we do support the current recommendations for vitamin D intakes and supplementation [31,38,39,40,41,42].